APPLIED THERAPEUTICS INC (APLT)

US03828A1016 - Common Stock

6.86  +0.01 (+0.15%)

News Image
22 days ago - Applied Therapeutics

Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results

NDA for govorestat accepted and granted Priority Review by FDA for the treatment of Classic Galactosemia; PDUFA target action date of August 28, 2024; MAA...

News Image
a month ago - InvestorPlace

Why Is Coupang (CPNG) Stock Up 4% Today?

Coupang stock is rallying on Wednesday as investors in CPNG celebrate the company beating out EPS and revenue estimates for Q4.

News Image
a month ago - InvestorPlace

Why Is Applied Therapeutics (APLT) Stock Up 59% Today?

Applied Therapeutics stock is rising higher on Wednesday alongside heavy trading of APLT following an update from the FDA.

News Image
a month ago - Seeking Alpha

Applied Therapeutics up 51% pre-market after announcing $100M equity raise (NASDAQ:APLT)

Applied Therapeutics (APLT) saw a significant boost in pre-market trade, with shares rising 51.5% after announcing plans to raise $100M through a private...

News Image
a month ago - Applied Therapeutics

Applied Therapeutics Announces $100 Million Private Placement

Financing includes significant participation from a number of large healthcare dedicated institutional and mutual fund investors Net proceeds, along with...

News Image
a month ago - Applied Therapeutics

Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia

PDUFA target action date of August 28, 2024 MAA validated and accepted for review by EMA in December 2023 NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) --...

News Image
a month ago - Seeking Alpha

Applied Therapeutics stock gains on trial win (NASDAQ:APLT)

Applied Therapeutics (APLT) sotck rises as its late-stage trial for lead asset govorestat hits main goals in Sorbitol Dehydrogenase ((SORD)) Deficiency. Read more here.

News Image
3 months ago - InvestorPlace

Intellia Therapeutics Layoffs 2024: What to Know About the Latest NTLA Job Cuts

Intellia Therapeutics layoffs are in the news on Friday as the biotech company prepares to cut its total workforce by 15% to reduce costs.

News Image
3 months ago - InvestorPlace

Why Is Safe and Green Development (SGD) Stock Up 50% Today?

Safe and Green Development stock is up on Friday as investors in SGD celebrate the company's plans to acquire Majestic World Holdings.

News Image
3 months ago - InvestorPlace

Why Is Applied Therapeutics (APLT) Stock Down 30% Today?

Applied Therapeutics stock is tumbling on Friday as investors react to lackluster results from a Phase 3 clinical trial of AT-001.

News Image
3 months ago - Seeking Alpha

Agilon Health, Medical Properties, Catalyst Pharmaceuticals among premarket losers' pack

Applied Therapeutics APLT -29% on mixed results from a Phase 3 study of its drug AT-001, which showed no significant difference in improvement or stabilization of cardiac functional capacity

News Image
3 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Pre-market stock movers are worth checking on Friday as we lay out all of the biggest stories worth keeping tabs on this morning!

News Image
3 months ago - Seeking Alpha

Applied Therapeutics stock plunges 30% on Phase 3 data for cardiac drug (NASDAQ:APLT)

Applied Therapeutics (APLT) stock plunged 30% in post-market trading Thursday after the biotech company reported mixed results from a Phase 3 study of its drug

News Image
3 months ago - Applied Therapeutics

Applied Therapeutics Announces Topline Results from the ARISE-HF Phase 3 Study of AT-001 in Diabetic Cardiomyopathy

AT-001 (caficrestat) demonstrated a strong trend in stabilizing cardiac functional capacity, while the placebo group declined over 15 months AT-001...

News Image
3 months ago - Seeking Alpha

Applied Therapeutics stock jumps 10% on FDA, EMA submissions (NASDAQ:APLT)

Applied Therapeutics stock surges 10% as the company submits applications for FDA and EU approval for its drug govorestat in galactosemia treatment.